Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey

BACKGROUND AND OBJECTIVES: Immune-checitors have been established as a novel standard treatment for non-small cell lung cancer (NSCLC). The aim of this study was to identify factors associated with efficacy and nivolumab-related interstitial pneumonia in NSCLC by evaluating clinical data at the init...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Hiroki, Mio, Tadashi, Yamashita, Daisuke, Matsumura, Chikako, Chisaki, Yugo, Motohashi, Hideyuki, Yano, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480353/
https://www.ncbi.nlm.nih.gov/pubmed/33297768
http://dx.doi.org/10.1177/1073274820977200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480353/
https://www.ncbi.nlm.nih.gov/pubmed/33297768
http://dx.doi.org/10.1177/1073274820977200

Ejemplares similares